Loading...
Price History
Market Data
| Market Cap | 101.11M |
| P/E Ratio | - |
| P/B Ratio | - |
| EPS | - |
| Dividend Yield | - |
| D/E Ratio | - |
| Current Ratio | 4.84 |
| Currency | USD |
Key Financial Metrics
982.02M
Revenue
-416.28M
Net Income
-
EPS (Diluted)
-433.30M
Free Cash Flow
Profitability
Gross Margin
64.5%
Operating Margin
-44.5%
Net Profit Margin
-42.4%
EBITDA
-367.00M
Returns & Efficiency
Return on Assets (ROA)
-20.7%
Return on Equity (ROE)
-
Dividend Yield
-
EPS
-
Financial Health
Total Assets
2.01B
Total Debt
1.50B
Debt to Equity
-
Current Ratio
4.84
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Health Services |
| HQ | PALO ALTO, CA |
| Fiscal Year | 2025 |
Peers
NATERA, INC.
NTRA
30.11B
P/E: --
21.23B
P/E: --
20.74B
P/E: --
20.74B
P/E: --
EXACT SCIENCES CORP
EXAS
9.06B
P/E: --
CELCUITY INC.
CELC
7.00B
P/E: --
5.32B
P/E: --
RADNET, INC.
RDNT
4.52B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$101.11M
P/E Ratio (TTM)-
Price to Book-
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin64.5%
Operating Margin-44.5%
Net Margin-42.4%
ROE-
ROA-20.7%
Leverage & Liquidity
Debt to Equity-
Current Ratio4.84
Total Debt$1.50B
Total Assets$2.01B
Stockholders' Equity$-99.31M
Income Statement (FY 2025)
Revenue$982.02M
Gross Profit$633.01M
Operating Income$-437.25M
Net Income$-416.28M
EPS (Diluted)-
Cash Flow (FY 2025)
Free Cash Flow$-433.30M
Cash & Equivalents$378.20M
Revenue Growth32.9%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 3100 HANOVER STREET PALO ALTO, CA 94304 |
| Phone | N/A |
| Incorporated | DE, US |
| EIN | 454139254 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 1.11M |
| Stockholders' Equity | $-99.31M |
| Cash & Equivalents | $378.20M |
Recent Filings
View All
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-30
Local
ARS
Annual Report to Shareholders
Annual report furnished to shareholders
Filed: 2026-04-28
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-28
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-04-28
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-27
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-22
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-20
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-16
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-16
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-04-16
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-07
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-04-06
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-19
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-18
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-18
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | Guardant Health, Inc. |
| Ticker | GH |
| Exchange | -- |
| Sector | Services |
| Industry | Health Services |
| Headquarters | PALO ALTO, CA |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 101.11M |
| Revenue | 982.02M |
| Net Income | -416.28M |
| P/E Ratio | - |
| EPS | - |
| Net Margin | -42.4% |
| ROE | - |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...